Related Experiment Videos

High dose caffeine and ventricular arrhythmias

M G Myers1, L Harris

  • 1Division of Cardiology, Sunnybrook Medical Centre, Toronto, Ontario.

Insights

High-dose caffeine (450 mg) did not increase ventricular arrhythmias in patients recovering from myocardial infarction. This study found similar rates of ventricular ectopy between caffeine and placebo groups, suggesting moderate doses are safe.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Recent myocardial infarction (MI) patients are at risk for ventricular arrhythmias.
  • Caffeine's pro-arrhythmic effects are a concern in cardiac patients.

Purpose of the Study:

  • To investigate the effect of high-dose caffeine on ventricular arrhythmias in patients with recent MI.

Main Methods:

  • A randomized, double-blind, placebo-controlled study.
  • 35 patients with recent MI received 450 mg caffeine or placebo on separate days.
  • 8-hour continuous Holter electrocardiographic monitoring was performed.

Main Results:

  • Caffeine did not increase the frequency or complexity of ventricular ectopy.
  • Ventricular arrhythmias occurred in 19/35 patients after caffeine versus 24/35 after placebo.
  • Serious ventricular ectopic activity (couplets, tachycardia) was similar between groups.

Conclusions:

  • Moderately high doses of caffeine do not appear to increase ventricular arrhythmias in patients with ischemic heart disease.
  • Caffeine may be safely used in this patient population at the doses studied.

Related Concept Videos